2-71526357-C-T

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PP3_ModerateBP6_Very_StrongBA1

The NM_001130987.2(DYSF):​c.1276+11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 1,473,386 control chromosomes in the GnomAD database, including 14,988 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1714 hom., cov: 31)
Exomes 𝑓: 0.14 ( 13274 hom. )

Consequence

DYSF
NM_001130987.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -2.83
Variant links:
Genes affected
DYSF (HGNC:3097): (dysferlin) The protein encoded by this gene belongs to the ferlin family and is a skeletal muscle protein found associated with the sarcolemma. It is involved in muscle contraction and contains C2 domains that play a role in calcium-mediated membrane fusion events, suggesting that it may be involved in membrane regeneration and repair. In addition, the protein encoded by this gene binds caveolin-3, a skeletal muscle membrane protein which is important in the formation of caveolae. Specific mutations in this gene have been shown to cause autosomal recessive limb girdle muscular dystrophy type 2B (LGMD2B) as well as Miyoshi myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 2-71526357-C-T is Benign according to our data. Variant chr2-71526357-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 94265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-71526357-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.195 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DYSFNM_001130987.2 linkuse as main transcriptc.1276+11C>T intron_variant ENST00000410020.8 NP_001124459.1
DYSFNM_003494.4 linkuse as main transcriptc.1180+11C>T intron_variant ENST00000258104.8 NP_003485.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DYSFENST00000258104.8 linkuse as main transcriptc.1180+11C>T intron_variant 1 NM_003494.4 ENSP00000258104 A1O75923-1
DYSFENST00000410020.8 linkuse as main transcriptc.1276+11C>T intron_variant 1 NM_001130987.2 ENSP00000386881 A1O75923-13

Frequencies

GnomAD3 genomes
AF:
0.150
AC:
21695
AN:
145092
Hom.:
1712
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.199
Gnomad AMI
AF:
0.173
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.104
Gnomad EAS
AF:
0.00635
Gnomad SAS
AF:
0.0889
Gnomad FIN
AF:
0.126
Gnomad MID
AF:
0.119
Gnomad NFE
AF:
0.144
Gnomad OTH
AF:
0.148
GnomAD3 exomes
AF:
0.116
AC:
28744
AN:
247926
Hom.:
2065
AF XY:
0.117
AC XY:
15717
AN XY:
134438
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.0737
Gnomad ASJ exome
AF:
0.107
Gnomad EAS exome
AF:
0.00349
Gnomad SAS exome
AF:
0.0869
Gnomad FIN exome
AF:
0.116
Gnomad NFE exome
AF:
0.144
Gnomad OTH exome
AF:
0.125
GnomAD4 exome
AF:
0.142
AC:
189023
AN:
1328178
Hom.:
13274
Cov.:
36
AF XY:
0.141
AC XY:
93290
AN XY:
659506
show subpopulations
Gnomad4 AFR exome
AF:
0.218
Gnomad4 AMR exome
AF:
0.0878
Gnomad4 ASJ exome
AF:
0.134
Gnomad4 EAS exome
AF:
0.00424
Gnomad4 SAS exome
AF:
0.0920
Gnomad4 FIN exome
AF:
0.149
Gnomad4 NFE exome
AF:
0.149
Gnomad4 OTH exome
AF:
0.147
GnomAD4 genome
AF:
0.149
AC:
21705
AN:
145208
Hom.:
1714
Cov.:
31
AF XY:
0.147
AC XY:
10364
AN XY:
70704
show subpopulations
Gnomad4 AFR
AF:
0.199
Gnomad4 AMR
AF:
0.122
Gnomad4 ASJ
AF:
0.104
Gnomad4 EAS
AF:
0.00660
Gnomad4 SAS
AF:
0.0878
Gnomad4 FIN
AF:
0.126
Gnomad4 NFE
AF:
0.144
Gnomad4 OTH
AF:
0.147
Alfa
AF:
0.131
Hom.:
286
Bravo
AF:
0.145
Asia WGS
AF:
0.0500
AC:
174
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxJan 25, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 24, 2015- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015c.1276+11C>T in intron 13 of DYSF: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus se quence. It has been identified in 18.7% (824/4406) of African American chromosom es from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs. washington.edu/EVS; dbSNP rs35982795). -
Qualitative or quantitative defects of dysferlin Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Limb-girdle muscular dystrophy, recessive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Distal myopathy with anterior tibial onset Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 30, 2021- -
not provided Benign:1
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Autosomal recessive limb-girdle muscular dystrophy type 2B Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 30, 2021- -
Miyoshi muscular dystrophy 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 30, 2021- -
Miyoshi myopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
23
DANN
Benign
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.93
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.93
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35982795; hg19: chr2-71753487; COSMIC: COSV50612274; API